Intervertebral Disc Repair Phase 2 Trial Update
MarketWatch (press release) - 16 minutes ago MELBOURNE, Australia, April 17, 2012 /PRNewswire via COMTEX/ -- Global regenerative medicine company Mesoblast Limited (asx:MSB) today announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, ...



More...